Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 18, 2013

Primary Completion Date

January 11, 2018

Study Completion Date

January 11, 2018

Conditions
LymphomaRelapse
Interventions
DRUG

Lenalidomide

DRUG

Rituximab

Trial Locations (12)

13005

Chu La Timone, Marseille

33076

Institut Bergonié, Bordeaux

37044

CHU Bretonneau - Centre Henry Kaplan, Tours

38043

Chu Michallon, Grenoble

39373

Centre Léon Bérard, Lyon

54036

Hôpital Central, Nancy

59037

CHRU Lille - Hôpital Claude Huriez, Lille

63003

CHU Estaing, Clermont-Ferrand

75013

Hôpital de la Pitié Salpétrière, Paris

76038

Centre Henri Becquerel, Rouen

80054

CHU Amiens -Hôpital Sud, Amiens

92210

Institut curie - Hôpital René Huguenin, Saint-Cloud

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire, Amiens

OTHER

collaborator

Institut Bergonié

OTHER

collaborator

University Hospital, Clermont-Ferrand

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Central Hospital, Nancy, France

OTHER

collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

collaborator

Centre Henri Becquerel

OTHER

collaborator

University Hospital, Tours

OTHER

collaborator

Centre Leon Berard

OTHER

collaborator

University Hospital, Grenoble

OTHER

lead

Institut Curie

OTHER